Alliance for Clinical Trials in Oncology
US cooperative group formed from CALGB, ACOSOG, and NCCTG; running OptimICE-pCR, which asks whether TNBC patients with a complete response still need a year of immunotherapy.
Formed 2011. NCI National Clinical Trials Network member. Trials include CALGB 40603 (carboplatin in TNBC), Z0011 (sentinel node without dissection), and A012103/OptimICE-pCR (omitting adjuvant pembrolizumab after pathologic complete response).
- NCTN cooperative group
- OptimICE-pCR
- Breast surgical de-escalation (Z0011)
GI oncologist who led CALGB/SWOG 80405 and helped show that tumour side matters in colorectal cancer.
Evanthia Galanis is a brain tumour specialist who chairs one of the largest US clinical trial networks.
Pages like this
not linked directly; found by shared links- InstitutionGerman Breast Group (GBG)
Shares Austrian Breast & Colorectal Cancer Study Group, Carboplatin, Triple-negative breast cancer (TNBC).
- PersonPriyanka Sharma
Shares Carboplatin, Pembrolizumab, Triple-negative breast cancer (TNBC).
- InstitutionBreast International Group (BIG)
Shares Austrian Breast & Colorectal Cancer Study Group, ETOP IBCSG Partners Foundation, Triple-negative breast cancer (TNBC).
- TrialSCARLET (SWOG S2212)
Shares Carboplatin, Pembrolizumab, Triple-negative breast cancer (TNBC).
- IdeaA funded programme of organ-preservation trials to avoid radical surgery
Shares A permanently funded international network for randomised cancer surgery trials, Pembrolizumab, Colorectal cancer.
- IdeaPrizes for unpatentable surgical and radiotherapy techniques proven in trials
Shares A permanently funded international network for randomised cancer surgery trials, Sentinel lymph node biopsy.
- IdeactDNA-triggered escalation in early TNBC
Shares OptimICE-pCR (A012103), Triple-negative breast cancer (TNBC).
- IdeaOne standing umbrella trial for all rare cancers in a country
Shares Trials enrol too few, too slowly, Neuroendocrine tumours, National Cancer Institute (NIH).
